Amoéba

Equities

ALMIB

FR0011051598

Agricultural Chemicals

Real-time Euronext Paris 09:09:29 2024-04-25 am EDT 5-day change 1st Jan Change
0.432 EUR -0.69% Intraday chart for Amoéba +5.37% +12.50%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Amoéba S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Amoéba: share price rises after strategic shift CF
Amoéba: CEO departure, industrial project postponed CF
Amoéba: 'convincing' results in cosmetics CF
Amoéba S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Global markets live: Ford, Standard Chartered, Apple, Unilever, General Motors... Our Logo
Amoéba S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Amoéba S.A. announced that it expects to receive €8.46 million in funding from Nice & Green SA CI
Amoéba: cancellation of OCA tranche issue CF
Amoéba Secures US Nod For Active Substance To Protect Plants MT
French Cleantech Amoéba Up 25% After US Regulator Approves Tolerance Exemption On Foodstuffs MT
Amoéba S.A. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Amoéba S.A. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Amoéba S.A. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Global markets live: Kering, Delta Air Lines, Pfizer, Moderna, Sony... Our Logo
Amoéba S.A. announced that it expects to receive €23.04 million in funding CI
Amoéba S.A. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Amoéba S.A. Reports Earnings Results for the Full Year Ended December 31, 2018 CI
Amoéba Reports Consolidated Earnings Results for the Year Ended December 31, 2017 CI
Amoéba Reports Consolidated Earnings Results for the First Half Ended June 30, 2017 CI
AMOEBA Signs A Distribution Agreement with DREWO CI
Amoéba Reports Consolidated Earnings Results for the Year Ended December 31, 2016 CI
Amoéba S.A. Extends It's Commercial Network in Italy CI
Amoeba S.A.(ENXTPA:AMEBA) added to MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index CI
Amoéba S.A. has completed an IPO in the amount of €13.216148 million. CI
Chart Amoéba
More charts
Amoéba specializes in the development, production and marketing of organic biocide for the treatment of legionella and amoebae in waters. This new disinfecting agent, Biomeba, destroys these pathogens without impact on water systems and the environment.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.435 EUR
Average target price
0.46 EUR
Spread / Average Target
+5.75%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALMIB Stock
  4. News Amoéba
  5. Amoéba Secures US Nod For Active Substance To Protect Plants